Clinical Trials Browser

Phase 1/2 × ribociclib × Dermatologic × Clear all

NCT01777776 2016-09-13

Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.

Phase 1/2 Terminated

28 enrolled 14 charts

Melanoma